Warren G. Magnuson Clinical Center (CC)
Bethesda, Maryland, 20892, United States
NCT Number: NCT00001518
The Groshong and Groshong PICC catheters are popular venous access devices because they are maintained with only weekly saline flushes. In a recent study, however, we found an apparent decrease in the rate of withdrawal occlusion in Groshong catheters flushed weekly with heparinized saline. However, a randomized trial is necessary to confirm this impression. In the current study as many as 66 patients will be randomized to each of two treatment arms. The Groshong catheters of one group will be flushed with saline only and the other group with heparinized saline. A comparison will be made between the frequency with which urokinase is used in the two groups to treat withdrawal occlusion during the first three months of catheterization. Groshong catheters using saline flushes will be compared to Groshong catheters using heparinized saline flushes and Groshong PICC catheters using saline flushes will be compared to Groshong PICC catheters using heparinized saline flushes. Data will be analyzed using Fisher's exact test.
Looking for future studies?
Notify MeAll sexes
Observational
Bethesda, Maryland, 20892, United States
The Groshong and Groshong PICC catheters are popular venous access devices because they are maintained with only weekly saline flushes. In a recent study, however, we found an apparent decrease in the rate of withdrawal occlusion in Groshong catheters flushed weekly with heparinized saline. However, a randomized trial is necessary to confirm this impression. In the current study as many as 66 patients will be randomized to each of two treatment arms. The Groshong catheters of one group will be flushed with saline only and the other group with heparinized saline. A comparison will be made between the frequency with which urokinase is used in the two groups to treat withdrawal occlusion during the first three months of catheterization. Groshong catheters using saline flushes will be compared to Groshong catheters using heparinized saline flushes and Groshong PICC catheters using saline flushes will be compared to Groshong PICC catheters using heparinized saline flushes. Data will be analyzed using Fisher's exact test.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Adult subjects enrolled in approved protocols of the NCI in the CC or under treatment at the National Naval Medical Center who are planned to have Groshong Catheters used as part of their cancer treatment.
No subjects with a history of allergy to heparin.
No abnormal PT or PTT.
No subjects on anticoagulant therapy.
No history of heparin induced thrombocytopenia.
National Institutes of Health Clinical Center (CC)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00073515
Cardiovascular Diseases, Catheters, Indwelling
Cleveland, Ohio, United States
View Trial DetailsNCT07006038
Catheter Complications, Catheterization, Peripheral
Izmir, Turkey (Türkiye)
View Trial DetailsNCT03351725
Catheter-Related Infections, Catheters, Indwelling
Jönköping, Småland, Sweden
View Trial DetailsNCT00272623
Catheters, Indwelling
Zurich, Canton of Zurich, Switzerland
View Trial Details